The present invention relates to an aqueous binder composition comprising:at least one polymer P having a glass transition temperature Tg in the range from \u221220 to +60\xb0 C. A master runtime system process is executed. The present invention yet further relates to methods of remotely and intelligently or automatically tuning a therapy device using objective quantified movement disorder symptom data to determine the therapy setting or parameters to be transmitted and provided to the subject via his or her therapy device. The remote network node configuration can include a remote range and a remote location. The extracted text data is sent to the image processing server together with printed image data. Once the lesion is solidified, the catheter is removed and the lesion can be treated with a conventional intravascular device.